BUNGE GLOBAL SA (BG)

CH1300646267 - Common Stock

91.31  +0.71 (+0.78%)

After market: 91.31 0 (0%)

Fundamental Rating

6

Taking everything into account, BG scores 6 out of 10 in our fundamental rating. BG was compared to 90 industry peers in the Food Products industry. BG has an excellent profitability rating, but there are some minor concerns on its financial health. BG is valued quite cheap, but it does not seem to be growing. These ratings could make BG a good candidate for value investing.



7

1. Profitability

1.1 Basic Checks

In the past year BG was profitable.
BG had a positive operating cash flow in the past year.
Of the past 5 years BG 4 years were profitable.
In the past 5 years BG reported 4 times negative operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 8.84%, BG belongs to the best of the industry, outperforming 86.52% of the companies in the same industry.
BG's Return On Equity of 20.67% is amongst the best of the industry. BG outperforms 87.64% of its industry peers.
BG has a Return On Invested Capital of 13.58%. This is amongst the best in the industry. BG outperforms 91.01% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BG is above the industry average of 9.03%.
The 3 year average ROIC (12.86%) for BG is below the current ROIC(13.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROIC 13.58%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.59%
ROE(5y)12.18%
ROIC(3y)12.86%
ROIC(5y)10.32%

1.3 Margins

BG has a better Profit Margin (3.77%) than 60.67% of its industry peers.
BG's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 5.34%, BG is in line with its industry, outperforming 59.55% of the companies in the same industry.
In the last couple of years the Operating Margin of BG has grown nicely.
BG has a worse Gross Margin (8.15%) than 75.28% of its industry peers.
In the last couple of years the Gross Margin of BG has grown nicely.
Industry RankSector Rank
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
OM growth 3Y17.85%
OM growth 5Y25.08%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.61%
GM growth 5Y10.47%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BG is creating some value.
Compared to 1 year ago, BG has more shares outstanding
Compared to 5 years ago, BG has more shares outstanding
BG has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.36 indicates that BG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.36, BG belongs to the top of the industry, outperforming 84.27% of the companies in the same industry.
BG has a debt to FCF ratio of 2.23. This is a good value and a sign of high solvency as BG would need 2.23 years to pay back of all of its debts.
BG's Debt to FCF ratio of 2.23 is fine compared to the rest of the industry. BG outperforms 79.78% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that BG is not too dependend on debt financing.
BG has a Debt to Equity ratio (0.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.23
Altman-Z 4.36
ROIC/WACC1.53
WACC8.89%

2.3 Liquidity

A Current Ratio of 2.13 indicates that BG has no problem at all paying its short term obligations.
BG has a better Current ratio (2.13) than 71.91% of its industry peers.
BG has a Quick Ratio of 1.20. This is a normal value and indicates that BG is financially healthy and should not expect problems in meeting its short term obligations.
BG has a better Quick ratio (1.20) than 69.66% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.2

2

3. Growth

3.1 Past

BG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.55%.
The Earnings Per Share has been growing by 38.94% on average over the past years. This is a very strong growth
The Revenue for BG has decreased by -11.44% in the past year. This is quite bad
BG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.41% yearly.
EPS 1Y (TTM)-18.55%
EPS 3Y19.26%
EPS 5Y38.94%
EPS Q2Q%-23.41%
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Sales Q2Q%-9.27%

3.2 Future

BG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.77% yearly.
BG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.83% yearly.
EPS Next Y-29.12%
EPS Next 2Y-16.28%
EPS Next 3Y-9.77%
EPS Next 5YN/A
Revenue Next Year-11.79%
Revenue Next 2Y-6%
Revenue Next 3Y-2.83%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.49, the valuation of BG can be described as very reasonable.
Based on the Price/Earnings ratio, BG is valued cheaply inside the industry as 95.51% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.65, BG is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.53, the valuation of BG can be described as reasonable.
Based on the Price/Forward Earnings ratio, BG is valued cheaper than 94.38% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.50. BG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.49
Fwd PE 9.53

4.2 Price Multiples

BG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BG is cheaper than 91.01% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BG indicates a rather cheap valuation: BG is cheaper than 92.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.83
EV/EBITDA 3.49

4.3 Compensation for Growth

The decent profitability rating of BG may justify a higher PE ratio.
A cheap valuation may be justified as BG's earnings are expected to decrease with -9.77% in the coming years.
PEG (NY)N/A
PEG (5Y)0.22
EPS Next 2Y-16.28%
EPS Next 3Y-9.77%

6

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 3.09%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.80, BG pays a bit more dividend than its industry peers.
BG's Dividend Yield is a higher than the S&P500 average which is at 2.22.
Industry RankSector Rank
Dividend Yield 3.09%

5.2 History

The dividend of BG has a limited annual growth rate of 4.77%.
BG has paid a dividend for at least 10 years, which is a reliable track record.
BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.77%
Div Incr Years4
Div Non Decr Years23

5.3 Sustainability

17.08% of the earnings are spent on dividend by BG. This is a low number and sustainable payout ratio.
DP17.08%
EPS Next 2Y-16.28%
EPS Next 3Y-9.77%

BUNGE GLOBAL SA

NYSE:BG (11/18/2024, 8:11:12 PM)

After market: 91.31 0 (0%)

91.31

+0.71 (+0.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap12.75B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.09%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.49
Fwd PE 9.53
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.22
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.13
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-18.55%
EPS 3Y19.26%
EPS 5Y
EPS Q2Q%
EPS Next Y-29.12%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y